|
1
|
Kieff E: Epstein-Barr virus and its
replicationFields Virology. Fields BN, Knipe DM and Howley PM: 3rd.
Lippincott-Raven; Philadelphia, PA: pp. 2343–2396. 1996
|
|
2
|
Shah KM and Young LS: Epstein-Barr virus
and carcinogenesis: Beyond Burkitt's lymphoma. Clin Microbiol
Infect. 15:982–988. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin JY, Kim JO, Lee SK, Chae HS and Kang
JH: LY294002 may overcome 5-FU resistance via down-regulation of
activated p-AKT in Epstein-Barr virus-positive gastric cancer
cells. Bmc Cancer. 10:4252010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takada K: Epstein-Barr virus and gastric
carcinoma. Mol Pathol. 53:255–261. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seo JS, Jun SM, Kwon SW, Oh IH, Kim TG and
Lee SK: Establishment and characterization of gastric carcinoma
cell clones expressing LMP2A of Epstein-Barr virus. Int N Mol Med.
25:11–16. 2010.
|
|
6
|
Iizasa H, Nanbo A, Nishikawa J, Jinushi M
and Yoshiyama H: Epstein-Barr virus (EBV)-associated gastric
carcinoma. Viruses. 4:3420–3439. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fukuda M and Longnecker R: Epstein-Barr
virus latent membrane protein 2A mediates transformation through
constitutive activation of the Ras/PI3-K/Akt Pathway. J Virol.
81:9299–9306. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Lin WH, Chen SY, Longnecker R, Tsai
SC, Chen CL and Tsai CH: Syk tyrosine kinase mediates Epstein-Barr
virus latent membrane protein 2A-induced cell migration in
epithelial cells. J Biol Chem. 281:8806–8814. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morrison JA and Raab-Traub N: Roles of the
ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A
in the inhibition of epithelial cell differentiation and activation
of {beta}-catenin signaling. J Virol. 79:2375–2382. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pan YR, Vatsyayan J, Chang YS and Chang
HY: Epstein-Barr virus latent membrane protein 2A upregulates
UDP-glucose dehydrogenase gene expression via ERK and PI3K/Akt
pathway. Cell Microbiol. 10:2447–2460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Allen MD, Young LS and Dawson CW: The
Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote
epithelial cell spreading and motility. J Virol. 79:1789–1802.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fotheringham JA, Coalson NE and Raab-Traub
N: Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk-
and Akt-dependent epithelial migration through αV-integrin membrane
translocation. J Virol. 86:10308–10320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fire A, Xu SQ, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O'Rourke JP, Newbound GC, Kohn DB, Olsen
JC and Bunnell BA: Comparison of gene transfer efficiencies and
gene expression levels achieved with equine infectious anemia
virus- and human immunodeficiency virus type 1-derived lentivirus
vectors. J Virol. 76:1510–1515. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han J, Chen JN, Zhang ZG, Li HG, Ding YG,
Du H and Shao CK: Sequence variations of latent membrane protein 2A
in Epstein-Barr virus-associated gastric carcinomas from Guangzhou,
southern China. PloS One. 7:e342762012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fukayama M and Ushiku T: Epstein-Barr
virus-associated gastric carcinoma. Pathol Res Pract. 207:529–537.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fukuda M and Longnecker R: Epstein-Barr
virus latent membrane protein 2A mediates transformation through
constitutive activation of the Ras/P13-K/Akt pathway. J Virol.
81:9299–9306. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scholle F, Bendt KM and Raab-Traub N:
Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell
differentiation and activates Akt. J Virol. 74:10681–10689. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stewart S, Dawson CW, Takada K, Curnow J,
Moody CA, Sixbey JW and Young LS: Epstein-Barr virus-encoded LMP2A
regulates viral and cellular gene expression by modulation of the
NF-kappaB transcription factor pathway. Proc Natl Acad Sci USA.
101:15730–15735. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH,
Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, et al: Epstein-Barr
virus-encoded LMP2A induces an epithelial-mesenchymal transition
and increases the number of side population stem-like cancer cells
in nasopharyngeal carcinoma. PloS Pathog. 6:e10009402010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lan YY, Hsiao JR, Chang KC, Chang JS, Chen
CW, Lai HC, Wu SY, Yeh TH, Chang FH, Lin WH, et al: Epstein-Barr
virus latent membrane protein 2A promotes invasion of
nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction
of matrix metalloproteinase 9. J Virol. 86:6656–6667. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Portis T and Longnecker R: Epstein-Barr
virus (EBV) LMP2A mediates B-lymphocyte survival through
constitutive activation of the Ras/PI3K/Akt pathway. Oncogene.
23:8619–8628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pal AD, Basak NP, Banerjee AS and Banerjee
S: Epstein-Barr virus latent membrane protein-2A alters
mitochondrial dynamics promoting cellular migration mediated by
Notch signaling pathway. Carcinogenesis. 35:1592–1601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pang MF, Lin KW and Peh SC: The signaling
pathways of Epstein-Barr virus-encoded latent membrane protein 2A
(LMP2A) in latency and cancer. Cell Mol Biol Lett. 14:222–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Izquierdo M: Short interfering RNAs as a
tool for cancer gene therapy. Cancer Gene Ther. 12:217–227. 2005.
View Article : Google Scholar : PubMed/NCBI
|
